<DOC>
	<DOCNO>NCT00152997</DOCNO>
	<brief_summary>The objective trial investigate efficacy safety pramipexole ( 0.125-0.75 mg ) orally daily compare placebo 6 week patient primary restless legs syndrome ( RLS ) investigate reliability Japanese version RLS rating scale International Restless Legs Syndrome Study Group ( IRLSSG ) sub-study .</brief_summary>
	<brief_title>Pramipexole ( BI-SifrolÂ® ) Orally Once Daily 6 Weeks Patients With Primary Restless Legs Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>According essential diagnostic criterion RLS NIH IRLSSG , follow four criterias must present : 1 . An urge move leg , usually accompany cause uncomfortable unpleasant sensation legs 2 . The urge move unpleasant sensation begin worsen period rest inactivity lie sit 3 . The urge move unpleasant sensation partially totally relieved movement , walk stretch , least long activity continue 4 . The urge move unpleasant sensation worse even night day occur even night PLM ( time bed ) index least 5 per hour ( bad affect leg ) Visit 3 Total score RLS severity scaleJapanese version IRLSSG &gt; 15 Visit 3 At least 1 time per week RLS symptom interfere sleep within last one month Visit 1 . 1 . Premenopausal woman meet one follow ( 1 ) ( 3 ) : Pregnant possibly pregnant In lactation Desire pregnant study period Even patient confirm fall criterion initiation study , patient childbearing potential , pregnancy test perform possible . If pregnancy test positive , investigational product discontinue . 2 . Males use adequate form contraception . 3 . Patients take neuroleptic within 4 week screen Visit 1 , neurolepticinduced akathisia . 4 . Patients stop treatment medication dietary supplement , could significantly influence RLS symptom washout least 14 day drug administration ( refer Appendix 3 prohibit medication ) , e.g . dopaminergic drug ( levodopa dopamine agonist ) antidopaminergic drug ( neuroleptic metoclopramide etc . ) , MAO inhibitor , sympathomimetics , antidepressant , hypnotic , benzodiazepine , antiepileptic , opioids , clonidine , magnesium , ferrous salt , folic acid , vitamin B12 , antihistaminics , lithium , melatonin . 5 . Patients diabetes mellitus require insulin therapy . 6 . Patients microcytic anemia investigator discretion . 7 . History clinical sign peripheral neuropathy ( PNP ) origin physical , neurological examination , myelopathy multiple sclerosis neurological disease , potential secondarily cause RLS symptom . 8 . Other sleep disorder , , REM sleep behaviour disorder , narcolepsy sleep apnea syndrome ( AHI &gt; 15 Visit 3 , history loud snore occur least 5 night week combine history breathe pause sleep excessive daytime sleepiness ) . 9 . Clinically significant renal disease creatinine high upper limit normal ( ULN ) screening .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>